Plus Therapeutics is running a dose optimization trial for REYOBIQ™ in alignment with FDA's Project Optimus.

The entities involved

• Plus Therapeutics →

  biopharmaceutical company

  Nothing else this week.

• FDA →
  • The illegal U.S. vape market is estimated to be worth $9 billion, fueled by unauthorized imports from China, while products must meet FDA authorization standards.Sun 20:36
  • VDPHL01 and Veradermics, Incorporated are seeking FDA approval for their lead therapies targeting hair loss.Sun 20:31

Related events

• EyePoint Pharmaceuticals developed its LUCIA trial program in alignment with the FDA, with enrollment noted in Lugano.Jun 8
• Arthur Caplan questioned the FDA regarding the status of clinical trials in 2006.Thu 21:26